FLI
GILD icon

Family Legacy Inc’s Gilead Sciences GILD Stock Holding History

Family Legacy Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,435
Closed -$243K – 68
2017
Q2 		$243K Sell
3,435
-1,865
-35% -$124K 0.24% 86
2017
Q1 		$360K Buy
+5,300
New +$373K 0.38% 71

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Family Legacy Inc's GILD Position: Q3 2017 in Review

Family Legacy Inc sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 3,435 shares — an estimated $243K sold.

Family Legacy Inc first reported a position in GILD in Q1 2017 and held it in 2 quarters. The position peaked at $360K in Q1 2017. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Family Legacy Inc reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Family Legacy Inc sold 3,435 Gilead Sciences shares in Q3 2017, an estimated $243K.
  • Family Legacy Inc first reported a position in Gilead Sciences in Q1 2017 and held it in 2 quarters.
  • Family Legacy Inc's Gilead Sciences position peaked at $360K in Q1 2017.
  • 1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Family Legacy Inc's 13F filing for Q3 2017, filed 15 Nov 2017.